Chiara Biagioni

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

Marta Pestrin, Silvia Bessi, Francesca Galardi et al. · Breast Cancer Research and Treatment · 2009 · 201 citations · Full text

Her2 Status, Breast Oncology, Endocrine-related Cancer +9

A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer

Luca Malorni, Silvano Piazza, Yari Ciani et al. · Oncotarget · 2016 · 151 citations · Full text

Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer

Cristina Guarducci, Martina Bonechi, Matteo Benelli et al. · npj Breast Cancer · 2018 · 123 citations · Full text

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

Luca Malorni, Giuseppe Curigliano, Alessandro Marco Minisini et al. · Annals of Oncology · 2018 · 94 citations · Full text

Redox regulation of platelet-derived-growth-factor-receptor: Role of NADPH-oxidase and c-Src tyrosine kinase

Serena Catarzi, Chiara Biagioni, Elisa Giannoni et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2005 · 59 citations

Redox Regulation, Redox Biology, Cellular Physiology +16